Trial Profile
A Prospective Study Investigating Association of Expression of TK1 in Plasma-Derived Exosomes with Clinical Response to Palbociclib in Metastatic Breast Cancer Patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Jun 2018
Price :
$35
*
At a glance
- Drugs Palbociclib (Primary) ; Fulvestrant; Letrozole
- Indications Advanced breast cancer
- Focus Pharmacodynamics; Pharmacogenomic; Therapeutic Use
- 15 Jun 2018 New trial record
- 05 Jun 2018 Results (n=16) of the first clinical evaluation for mRNA levels and efficacy, presented at the 54th Annual Meeting of the American Society of Clinical Oncology.